Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Akoya Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Akoya Biosciences, Inc.’s stock price such as:

• Akoya Biosciences, Inc.’s current stock price and volume
• Why Akoya Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for AKYA from analysts
• AKYA’s stock price momentum as measured by its relative strength

About Akoya Biosciences, Inc. (AKYA)

Before we jump into Akoya Biosciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Want to learn more about Akoya Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Akoya Biosciences, Inc..

Akoya Biosciences, Inc.’s Stock Price as of Market Close

As of June 11, 2025, 1:46 PM, CST, Akoya Biosciences, Inc.’s stock price was $1.340.

Akoya Biosciences, Inc. is up 0.75% from its previous closing price of $1.330.

During the last market session, Akoya Biosciences, Inc.’s stock traded between $1.290 and $1.370. Currently, there are approximately 49.66 million shares outstanding for Akoya Biosciences, Inc..

Akoya Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Akoya Biosciences, Inc. Stock Price History

Akoya Biosciences, Inc.’s (AKYA) price is currently up 7.2% so far this month.

During the month of June, Akoya Biosciences, Inc.’s stock price has reached a high of $1.370 and a low of $1.090.

Over the last year, Akoya Biosciences, Inc. has hit prices as high as $3.420 and as low as $0.931. Year to date, Akoya Biosciences, Inc.’s stock is down 41.48%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Akoya Biosciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of June 10, 2025,, no analysts have changed their rating of Akoya Biosciences, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Akoya Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Akoya Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Akoya Biosciences, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Akoya Biosciences, Inc. (AKYA) by visiting AAII Stock Evaluator.

Relative Price Strength of Akoya Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 10, 2025, Akoya Biosciences, Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 16 and is considered to be Very Weak.

Want to learn more about how Akoya Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Akoya Biosciences, Inc. Stock Price: Bottom Line

As of June 11, 2025, Akoya Biosciences, Inc.’s stock price is $1.340, which is up 0.75% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Akoya Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.